A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.
Clinical trial NCT07521345 · RECRUITING
Trial details
- NCT number
- NCT07521345
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-20
- Primary completion
- 2026-06-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.